The Company

INFAI is at the leading edge in the transfer of advanced analytical technology into medical diagnostics and the development of innovative pharmaceutical products. The company has pioneered the use of stable isotopes and NMR in gastroenterology, metabolic diseases and oncology. INFAI 's laboratories in Bochum, Germany are equipped with the most advanced NMR and NMR imaging instrumentation. These facilities are used for in house research and product development and are also available for collaborative and contract research.

The last five years has seen the development of a range of non-invasive and highly effective stable isotope breath tests. One of these tests is already licensed and available for the routine diagnosis of Helicobacter pylori infection. Other tests to determine gastric emptying rate and pancreatic insufficiency are completing clinical trials and will be available very soon.

NMR spectroscopy and NMR imaging are used at INFAI to investigate a range of metabolic disorders and malignant conditions. The non-invasive characteristics of these techniques make them particularly suitable for pediatric use.

INFAI and it's affiliate companies throughout Europe can be contacted at the addresses shown below.